Bruton agammaglobulinemia, also known as X-linked agammaglobulinemia (XLA) or Bruton’s agammaglobulinemia, is an inherited immunodeficiency disorder. It is characterized by the absence of mature B cells which in turn leads to severe antibody deficiency and recurrent infections. It can manifest in an infant as soon as the protective effect of maternal immunoglobulins wanes at around six months of age. This activity reviews Bruton agammaglobulinemia and highlights the role of the interprofessional team in its evaluation and management.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/18674
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABP - 1.0 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Adolescent Medicine, Clinical Pathology, General Pediatrics, General Surgery, Hematology, Hematology (Blood, BM), Hematopathology (LN, Spleen), Hemostasis & Thrombosis/Coagulation, Hospital Medicine, Infectious Disease, Internal Medicine, Medical Oncology, Molecular Genetic Pathology, Neonatal-Perinatal Medicine, Pediatric Critical Care Medicine, Pediatric Emergency Medicine, Pediatric Hematology-Oncology, Pediatric Infectious Diseases
Subscribe
Login
0 Comments
Oldest